CPRIT Annual Conference

"Understanding and Learning from Early Stage Cancers"

Ronald A. DePinho, M.D., President, University of Texas MD Anderson Cancer Center

"RE-AIMing How We Plan, Implement and Evaluate Cancer Prevention Programs"

Russ Glasgow, Ph.D., Deputy Director for Dissemination and Implementation Science in the Division of Cancer Control and Population Sciences, National Cancer Institute

“CTNeT:  The Strategic Plan and Vision"

• David Johnson, M.D., F.A.C.P, Chairman of Internal Medicine, University of Texas Southwestern Medical School
• Charles E. Geyer, Jr., M.D., F.A.C.P., Chief Medical Officer, CTNeT

“Applying Evidence-based Strategies to Enhance Cancer Control”

Barbara Rimer, Dr.PH, Dean, Alumni Distinguished Professor, University of North Carolina Gillings School of Global Public Health

"Launching a Cancer Genetic Laboratory to Enhance Diagnosis and Treatment"

• Richard Gibbs, Ph.D., Director, Human Genome Sequencing Center, Baylor College of Medicine
• Arthur L. Beaudet, M.D. Professor, Deptartment of Molecular and Human Genetics, Baylor College of Medicine

"Building a Sustainable BioScience Commercialization Community in Texas"

Moderated By: Charles Tate, CPRIT Oversight Committee Member

Participants:

• Jodey Arrington, Texas Tech University System
• Joseph S. Bailes, M.D., CPRIT Oversight Committee
• Ronald A. DePinho, M.D., The University of Texas MD Anderson Cancer Center
• Guy Diedrich, Texas A&M University System

Research & Prevention Abstract Presentations

"Personalized Medicine and Targeted Therapies: Where We are Going"

Moderated By: Joseph S. Bailes, M.D., CPRIT Oversight Committee

Participants:

• Steven Stein, M.D., Novartis Pharmaceuticals Corporation
• Jamey Skillings, M.D., Pfizer, Inc.

"Bringing Together Innovation, Investment and Industry"

Moderated By: Robert D. Ulrich, Ph.D., Managing Partner, Vanguard Ventures

Participants:

• Zafrira Avnur, M.D., Head, Global Academic Innovation Partnering, Roche Pharmaceuticals
• Kevin M. Lalande, Managing Director, Sante Ventures
• Robert C. Young, M.D., President, RCY Medicine

Research & Prevention - Abstract Presentations

“The Paradox of Prevention: Putting What We Know Will Work Into Practice”

Harvey Fineberg, M.D., Ph.D., President, Institute of Medicine, Professor, Health Policy and Management, Harvard School of Public Health

"Molecular Characterization of Lung Cancer Progression"

Tyler Jacks, Ph.D., Director, David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology

“Glioblastoma: Basic to Applied”

• Luis Parada , Ph.D., Chairman, Developmental Biology, University of Texas Southwestern Graduate School of Biomedical Sciences
• Donald Parsons, M.D., Ph.D., Assistant Professor, Department of Pediatrics/Hematology-Oncology, Baylor College of Medicine

"From Prevention to Survivorship"

Moderated By: Emily Ramshaw, Deputy Editor, Texas Tribune

Participants:

• Lance Armstong, LIVESTRONG
• The Honorable Jason Isaac, Texas House of Representatives
• Ana Sierra, Community Action, Inc.

Abstract Presentations

CPRIT Prevention Grantee Networking Session

"Glioblastoma: Basic to Applied"

• Elizabeth A. Maher, M.D., Ph.D., Associate Professor Internal Medicine, Hematology-Oncology, University of Texas Southwestern Medical School
• Malcolm K. Brenner, M.D., Ph.D., Professor, Department of Pediatrics, Hematology-Oncology, Baylor College of Medicine

Abstract Presentations

CPRIT Prevention Grantee Networking Session

Presentation on CPRIT Virtual Management Company "Texas BioAlliance: Supporting Commercialization of CPRIT-Funded Oncology Research"

• Jacqueline Northcut, CEO, Texas Bio Alliance
• Paul Cossum, Ph.D., President, Texas BioAlliance
• Jeff Bockman, Ph.D., Defined Health

"Bench to Bedside: Translation of Targeted Therapies in Multiple Myeloma"

Kenneth C. Anderson, M.D., Kraft Family Professor of Medicine, Harvard Medical School, Director, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute

"Survivors of Childhood Brain Tumors Entering the Adult World: Challenges and Avenues for Intervention"

Moderated By: Gail Tomlinson, M.D., Ph.D., Professor of Pediatrics and Division Director of Pediatric Hematology-Oncology, University of Texas Health Science Center San Antonio

Participants:

• Daniel C. Bowers, M.D., Associate Professor of Pediatrics, University of Texas Southwestern Medical Center, Director, After the Cancer Experience (ACE) Program
• M. Douglas Ris, Ph.D., ABPP-CN, Professor and Head, Section of Psychology, Department of Pediatrics, Baylor College of Medicine, Chief of Psychology, Texas Children’s Hospital

“There’s More Than A Lonestar in Texas” (Part 1)

• Jessica Tyler, Ph.D., Professor, Biochemistry and Molecular Biology, University of Texas MD Anderson Cancer Center
• Joshua Mendell, M.D., Ph.D., Professor, Molecular Biology, University of Texas Southwestern Medical Center

"We Worked Hard....But Did the Program Work?" Helpful Answers to Evaluation Questions

Judith Ottoson, Ed.D., M.P.H., Independent Evaluation Consultant; Adjunct Lecturer, San Francisco State University

“There’s More Than A Lonestar in Texas” (Part 2)

• Nancy A. Jenkins, Ph.D., Institute of Molecular and Cell Biology
• Herbert Levine, Ph.D., Center for Theoretical Biological Physics

"CPRIT Funding:  Behind the Scores"

• Alfred Gilman, M.D., Ph.D, Nobel Laureate, CPRIT Chief Scientific Officer
• Jerry Cobbs, CPRIT Chief Commercialization Officer

"CPRIT Funding: Behind the Scores"

• Becky Garcia, Ph.D., CPRIT Chief Prevention Officer
• Lawrence Green, Dr.P.H., University of California San Francisco
• Heather Brandt, Ph.D., University of South Carolina Arnold School of Public Health
• DeAnn Lazovich, Ph.D., M.P.H., University of Minnesota